Advertisement

Topics

Search Results for "Colchicine And Rivaroxaban"

19:31 EDT 19th October 2017 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Rivaroxaban, Aspirin, or Both in Stable Coronary Disease (FREE)

The combination of rivaroxaban plus aspirin was shown to improve outcome, even when bleeding was factored in.

Global Colchicine Market Research Report Forecast 20172022 [Report Updated: 18062017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Colchicine Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It pr...

Combination therapy works best for heart diseases

A major international study has found that the combination of two drugs -- rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in people with vascular dis...

COMPASS: Rivaroxaban Success in Secondary CV Prevention

The combination of a low dose of the factor Xa inhibitor rivaroxaban in combination with aspirin was associated with a reduction in ischemic events and mortality and a superior net clinical benefit, b...

COMPASS: Rivaroxaban Reduces CV and Limb Events in PAD

The combination of low-dose rivaroxaban plus aspirin has become the first drug regimen to show a clear-cut reduction in both cardiovascular and limb events, including amputations, in patients with per...

Rivaroxaban OK for stroke prevention in cancer patients

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study publis...

Researchers find combination therapy works best for heart diseases

(McMaster University) A major international study has found that the combination of two drugs -- rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in pe...

Warfarin, rivaroxaban similarly safe, effective

(HealthDay)—For cases of mild atrial fibrillation (AF)-related acute ischemic stroke, rivaroxaban and warfarin are similarly safe and effective at preventing recurrent stroke, according to a study p...

Matching PubMed Articles

Use of colchicine in pregnancy: a systematic review and meta-analysis.

Colchicine is an anti-inflammatory agent used in the treatment of several rheumatological conditions. The use of colchicine in pregnancy is controversial. The current study aimed to systematically rev...

Microbial Catalyzed Regio-Selective Demethylation of Colchicine by Streptomyces griseus ATCC 13273.

Colchicinoids and their derivatives are of great importance in pharmaceutical applications, and colchicine is usually used as the first choice for the treatment of gout. To expand the structural diver...

Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?

Rivaroxaban is an oral direct Xa inhibitor that can lead to prolongation of prothrombin time and activated partial thromboplastin time. However, these basic coagulation tests are not specific for the ...

Interleukin-8 enhances the effect of colchicine on cell death.

Pro-inflammatory cytokines are known to be generated in tumors and play important roles in angiogenesis, mitosis, and tumor progression. However, few studies have investigated the synergistic effects ...

Activated charcoal significantly reduces the amount of colchicine released from Gloriosa superba in simulated gastric and intestinal media.

Poisoning with Gloriosa superba, a plant containing colchicine, is common in Sri Lanka.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement